» Articles » PMID: 24935606

Diabetes Mellitus As a Risk Factor for High Grade Renal Cell Carcinoma

Overview
Specialty Oncology
Date 2014 Jun 18
PMID 24935606
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes is a chronic disease characterized by impaired fasting blood glucose that leads to disturbances in various organs. In this study, we evaluated relationships between tumor size and grade in a population of diabetic and non-diabetic patients with renal cell carcinoma.

Materials And Methods: Between 2007-2013, in our clinic radical nephrectomy performed to 310 patients for renal tumors and pathology reported renal cell carcinoma cases were enrolled in the study. Patients with and without a history of diabetes regarding fasting glucose and HgA1c levels were evaluated during surgery for tumor size and Fuhrman grade.

Results: Diabetes was found in 95 patients. The mean age of the patients with and without diabetes mellitus was 64.3 (40-79) and 58.4 (31-87) years, respectively. In the diabetes group 51% of patients had a tumor size over 7 cm and 54% a tumor grade over Fuhrman 3. The respective figures in the non-diabetes group were 35% and 30% (p<0.05 in both cases).

Conclusions: Renal cancer appears more aggressive in patients with diabetes. In this study lifestyle and risk factors with diabetes regulation were observed to be important for renal cancer patients. Multicenter studies are needed in larger series for more accurate results.

Citing Articles

Knockout of the Carbohydrate Responsive Element Binding Protein Enhances Proliferation and Tumorigenesis in Renal Tubules of Mice.

Hansen K, Peters K, Burkert C, Brose E, Calvisi D, Ehricke K Int J Mol Sci. 2024; 25(21).

PMID: 39518998 PMC: 11545909. DOI: 10.3390/ijms252111438.


Incidence and Distribution of New Renal Cell Carcinoma Cases: 27-Year Trends from a Statewide Cancer Registry.

Alzubaidi A, Sekoulopoulos S, Pham J, Walter V, Fuletra J, Raman J J Kidney Cancer VHL. 2022; 9(2):7-12.

PMID: 35528728 PMC: 9021010. DOI: 10.15586/jkcvhl.v9i2.219.


Metabolic Syndrome is an Independent Risk Factor for Fuhrman Grade and TNM Stage of Renal Clear Cell Carcinoma.

Zhang Q, Chen P, Tian R, He J, Han Q, Fan L Int J Gen Med. 2022; 15:143-150.

PMID: 35023952 PMC: 8743490. DOI: 10.2147/IJGM.S346972.


Diabetes and kidney cancer risk among post-menopausal women: The Iowa women's health study.

Wang S, Lo Galbo M, Blair C, Thyagarajan B, Anderson K, Lazovich D Maturitas. 2020; 143:190-196.

PMID: 33308628 PMC: 8034547. DOI: 10.1016/j.maturitas.2020.07.010.


Renal cell cancer after kidney transplantation.

Kleine-Dopke D, Oelke M, Schwarz A, Schwager Y, Lehner F, Klempnauer J Langenbecks Arch Surg. 2018; 403(5):631-641.

PMID: 30003323 DOI: 10.1007/s00423-018-1694-x.